An, S. and Knox, K.A., “Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP,” FEBS Lett. 386:115-122 (1996). |
Black, R.A. et al., “A Pre-aspartate-specific Protease from Human Leukocytes That Cleaves Pro-interleukin-1β,” J. Biol. Chem. 264:5323-5326 (1989). |
Black, S.C. et al., “Co-localization of the Cysteine Protease Caspase-3 with Apoptotic Myocytes after In Vivo Myocardial Ischemia and Reperfusion in the Rat,” J. Mol. Cell. Cardiol. 30:733-742 (Apr. 1998). |
Conaldi, P.G. et al., “HIV-1 kills Renal Tubular Epithelial Cells in Vitro by Triggering an Apoptotic Pathway Involving Caspase Activation and Fas Upregulation,” J. Clin. Invest. 102:2041-2049 (Dec. 1998). |
del Pozo, O., and Lam, E., “Caspases and programmed cell death in the hypersensitive response of plants to pathogens,” Curr. Biol. 8:1129-1132 (Sep. 1998). |
Emery, E. et al., “Apoptosis after traumatic human spinal cord injury,” J. Neurosurg. 89:911-920 (Dec. 1998). |
Greenberg, J.T. et al., “Programmed Cell Death in Plants: A Pathogen-Triggered Response Activated Coordiantely with Multiple Defense Functions,” Cell 77:551-563 (1994). |
Hara, H. et al., “Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage,” Proc. Natl. Acad. Sci. USA 94:2007-2012 (Mar. 1997). |
Hiraoka, J. et al., “Participation of apoptosis in renal amyloidosis,” Jpn. J. Nephrol. 40:276-283 (May 1998). |
Jaeschke, H. et al., “Activation of Caspase 3 (CPP32)-Like Proteases Is Essential for TNF-α-Induced Hepatic Parenchymal Cell Apoptosis and Neutrophil-Mediated Necrosis in a Murine Endotoxin Shock Model,” J. Immun. 160:3480-3486 (Apr. 1998). |
Jones, R.A. et al., “Fas-Mediated Apoptosis in Mouse Hepatocytes Involves the Processing and Activation of Caspases,” Hepatology 27:1632-1642 (Jun. 1998). |
Kermer, P. et al., “Inhibition of CPP32-Like Proteases Rescues Axotomized Retinal Ganglion Cells from Secondary Cell Death In Vivo,” J. Neuroscience 18:4656-4662 (Jun. 1998). |
Kubo, S. et al., “Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors,” Proc. Natl. Acad. Sci. USA 95:9552-9557 (Aug. 1998). |
Lieberthal, W. et al., “Necrosis and Apoptosis in Acute Renal Failure,” Sem. Nephr. 18:505-518 (Sep. 1998). |
Lotem, J. and Sachs, L., “Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents,” Proc. Natl. Acad. Sci. USA 93: 12507-12512 (1996). |
Mattson, M.P. et al., “Amyloid β-peptide induces apoptosis-related events in synapses and dendrites,” Brain Res. 807:167-176 (Oct. 1998). |
Maulik, N. et al., “Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis,” Free Rad. Biol. & Med. 24:869-875 (Mar. 1998). |
Miller, P.E. et al., “Photoreceptor cell death by apoptosis in dogs with sudden acquired retinal degeneration syndrome,” Am. J. Vet. Res. 59:149-152 (Feb. 1998). |
Mundle, S. D. et al., “Evidence for involvement of Tumor Necrosis Factor-α in Apoptotic Death of Bone Marrow Cells in Myelodysplastic Syndromes,” Am. J. Hemat. 60:36-47 (Jan. 1999). |
Ortiz, A. et al., “Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases.” Kidney Int'l 68:S25-S29 (Dec. 1998). |
Rich, D.H., “Inhibitors of aspartic proteinases,” in Protein inhibitors. Research monographs in cell and tissue physiology. vol. 12, Barrett, A.J. and G. Salvesen, eds., Elsevier, Amsterdam, Holland, pp.179-208 (1986). |
Richberg, M.H. et al., “Dead cells do tell tales,” Curr. Op. Plant Biol. 1:480-485 (Dec. 1998). |
Sheikh, M.S. et al., “Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1,” Oncogene 17:2555-2563 (Nov. 1998). |
Sleath, P.R. et al., “Substrate Specificity of the Protease That Pocesses Human Interleukin-1β,” J. Biol. Chem. 265:14526-14528 (1990). |
Slomiany, B.L. et al., “Activation of Apoptotic Caspase-3 and Nitric Oxide Synthase-2 in Buccal Mucosa with Chronic Alcohol Ingestion,” Biochem. & Mol. Biol. Int'l. 45:1199-1209 (Sep. 1998). |
Suzuki, A., “The Dominant Role of CPP32 Subfamily in Fas-Mediated Hepatitis,” Proc. Soc. Exp. Biol. Med. 217:450-454 (Apr. 1998). |
Thornberry, N.A. et al., “A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B,” J. Biol. Chem. 272:17907-17911 (Jul. 1997). |
Alnemri, E.S., et al., “Human ICE/CED-3 Protease Nomenclature,” Cell 87:171 (1996). |
Angliker, H., et al., “The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathespin B,” Biochem J. 241:871-875 (1987). |
Bourne, E.J., et al., “Studies of Trifluoroacetic Acid. Part XVIII. Reaction of N-Aroylglycines with Perfluro-carboxylic Anhydrides,” J. Chem. Soc., pp. 1771-1775 (1961). |
Di Giovine, F.S., and Duff, G.W., “Interleukin 1: the first interleukin,” Immunol. Today 11:13-14 (1990). |
Dinarello, C.A., “Interleukin-1 and Interleukin-1 Antagonism,” Blood 77:1627-1652 (1991). |
Dolle, R.E., et al., “P1 Aspartate-Based Peptide α-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1β-Converting Enzyme,” J. Med. Chem. 37:563-564 (1994). |
Goldberg, Y.P., et al., “Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract,” Nature Genet. 13:442-449 (1996). |
Lepschy, J., “Acylierung von Oxazolinonen—(5) Unter Besonderer Berücksichtigung der Dakin-West-Reaktion Trifunktioneller Aminosäuren,” Ph.D. Thesis, The Technical University of Munich, Germany, 83 p. (1971). |
Miura, M., et al., “Induction of Apoptosis in Fibroblasts by IL-1β-Converting Enzyme, a Mammalian Homolog of the C. elegans Cell Death Gene ced-3,” Cell 75:653-660 (1993). |
Mosley, B., et al., “The Interleukin-1 Receptor Binds the Human Interleukin-1α Precursor but Not the Interleukin-1β Precursor,” J. Biol. Chem. 262:2941-2944 (1987). |
Oppenheim, J.J., et al., “There is more than one interleukin-1,” Immunol. Today 7:45-56 (1986). |
Rasnick, D., “Synthesis of Peptide Fluoromethyl Ketones and the Inhibition of Human Cathespin B,” Analyt. Biochem. 149:461-465 (1985). |
Rauber, P., et al., “The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteinases and cysteine proteinases,” Biochem. J. 239:633-640 (1986). |
Revesz, L., et al., “Synthesis of P1 Aspartate-Based Peptide Acyloxymethyl and Fluoromethyl Ketones as Inhibitors of Interleukin-1β-Converting Enzyme,” Tetrahedron Lett. 35:9693-9696 (1994). |
Rodriguez, I., et al., “Systemic Injection of a Tripeptide Inhibits the Intracellular Activation of CPP32-like Proteases In Vivo and Fully Protects Mice against Fas-mediated Fulminant Liver Destruction and Death,” J. Exp. Med. 184:2067-2072 (1996). |
Shaw, E., et al., “Peptidyl fluoromethyl ketones as thiol protease inhibitors,” Biomed. Biochim. Acta 45:1397-1403 (1986). |
Steinberg, D., “Caspase Inhibitors: Molecules Sought For Treatment of Diverse Disorders,” Genet. Engin. News 18:16, 38 and 51 (Jul. 1998). |
Thornberry, N.A., et al., “A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes,” Nature 356:768-774 (1992). |
Thornberry, N.A., “Caspases: key mediators of apoptosis,” Chem. Biol. 5:R97-R103 (May 1998). |
Xue, D., et al., “The time course for infarction in a rat model of transient focal ischemia,” Abstract No. 36, Stroke 21:166 (1990). |
Yuan, J., et al., “The C. elegans Cell Death Gene ced-3 Encodes a Protein Similar to Mammalian Interleukin-1β-Converting Enzyme,” Cell 75:641-652 (1993). |
Grobmyer, S.R. et al., “Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic Shock,” Mol. Med. 5:585-594 (Sep. 1999). |
Hotchkiss, R.S. et al., “Prevention of lymphocyte cell death in sepsis improves survival in mice,” PNAS 96:14541-14546 (Dec. 1999). |
Weil, M. et al., “Is programmed cell death required for neural tube closure?” Curr. Biol. 7:281-284 (Apr. 1997). |